Cannabinoid Receptor Antagonists

All categories
DBCAT001763Pharmacologic class

Compounds that inhibit or block the activity of CANNABINOID RECEPTORS. A DrugBank category of 6 drugs. 1 of them is approved.

Part of
Cannabinoids and similars
Also known as
Antagonists, Cannabinoid · Antagonists, Cannabinoid Receptor · Blockers, Cannabinoid · Blockers, Cannabinoid Receptor · Cannabinoid Antagonists
Drugs

What you can answer from here — as of June 29, 2018

6DrugsEach linked to its full drug card
Listed above
3Drug targetsEvery drug–target pair in the class, with bond type
Sign in
32Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
1Route of administrationHow the drugs in this class are given
Sign in
1SubcategoryNarrower classes within this one
Sign in

Which targets do Cannabinoid Receptor Antagonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In